Medical/Pharmaceuticals
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 12, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced thatFrederick Beddingfield, Chief Executive Officer of Kira Pharm...
CES 2021 PressureDOT develops the world's smallest real-time wireless intra-abdominal pressure sensing capsule
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Hospitals and health systems across the world are looking at telehealth strategies to facilitate their advance into the telemedicine industry. PressureDOT is at the forefront of remote critical monitoring with its recently developed, world's smallest wireless...
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories
MONTREAL, Jan. 12, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners ("Arsenal"), announced today the acquisition of Mosaic Laboratories LLC ("Mosaic"), aCalifornia-based company offering histology and immu...
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer
STOCKHOLM, Jan. 12, 2021 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish drug discovery company, andUniversity of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration agreement. The two parties will work together in a project aimed ...
IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection
OSAKA, Japan, Jan. 12, 2021 /PRNewswire/ -- H. IKEUCHI & CO., LTD., a leading manufacturer of industrial and commercial spray nozzles, headquartered inJapan, has launched full-scale sales of a backpack disinfection device dubbed "Dry-Fog HIGHNOW (R)." Logo: https://kyodonewsprwire.jp/prwfile/re...
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference BOSTON, Jan. 11, 2021 /PRNewswire/ -- Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of life-changin...
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41
SHANGHAI, Jan. 11, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the positive phase I clinical results of ASC41 oral ...
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio
MedSkin Solutions Dr. Suwelack AG announces receiving FDA 510(k) clearance for its flagship Med Care product portfolio MatriDerm®. HAMBURG, Germany, Jan. 12, 2021 /PRNewswire/ -- MatriDerm® is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine el...
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received
FDA clearance for its novel neuroendoscope, the Axonpen System, for
illumination and visualization of intracranial tissue and fluids, and the
controlled aspiration of tissue and/or fluid during surgery.
Regent Pacific Announces Key Research Findings On FORTACIN™
HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC). Yuyu Pharma (Yuyu) established its CP team in 2016 with the help of the law firm Kim & Chang. The CP tea...
PharmAbcine announces a research collaboration with LegoChem Biosciences
DAEJEON, South Korea, Jan. 11, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company has entered into a research collaboration agreement with LegoChem Bioscience...
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services
Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging, eClinical, and Regulatory solutions provider NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire/ -- Calyx, a leading provider of Medical Imaging, eClinical, and Regulatory solutions and services to solve complex challenges in c...
Airnov Made Its Debut at CPhI China
SHANGHAI, Jan. 11 2021 /PRNewswire/ -- Airnov Healthcare Packaging made its debut successfully at the CPhI China 2020 at Shanghai New International Expo Center on December 16-18. The global leader in healthcare packaging attended the event with its latest innovations including HAT® IN desiccant v...
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.
SHENZHEN, China, Jan. 11, 2021 /PRNewswire/ -- On January 8, 2021, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) submitted its pivotal phase III clinical trial application (IND) of national class I innovative drug Chiauranib to NMPA, for the treatment...
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference
SHANGHAI and SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology an...
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Standigm Inc.("Standigm"), an AI-based drug discovery company and SK Chemicals Co., Ltd.("SK Chemicals"), a life science and green chemicals company, announced that they had successfully found a new arthritis indication for an FDA-approved drug an...
Week's Top Stories
Most Reposted
Amorepacific Showcases Innovative Technologies at CES 2026
[Picked up by 292 media titles]
2026-01-05 12:14Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 284 media titles]
2026-01-08 12:01Radisson Hotel Group Revives Bangkok Icon with Opening of Radisson Hotel Chateau de Bangkok
[Picked up by 283 media titles]
2026-01-06 10:45Panduit Announces Key Executive Appointments to Support Strategic Growth and Innovation
[Picked up by 282 media titles]
2026-01-07 10:00